• Home
  • Search Results
  • Monitoring spatiotemporal changes in chaperone-mediated autophagy in vivo.

Monitoring spatiotemporal changes in chaperone-mediated autophagy in vivo.

Nature communications (2020-02-02)
S Dong, C Aguirre-Hernandez, A Scrivo, C Eliscovich, E Arias, J J Bravo-Cordero, A M Cuervo

Autophagy malfunctioning occurs in multiple human disorders, making attractive the idea of chemically modulating it with therapeutic purposes. However, for many types of autophagy, a clear understanding of tissue-specific differences in their activity and regulation is missing because of lack of methods to monitor these processes in vivo. Chaperone-mediated autophagy (CMA) is a selective type of autophagy that until now has only been studied in vitro and not in the tissue context at single cell resolution. Here, we develop a transgenic reporter mouse that allows dynamic measurement of CMA activity in vivo using image-based procedures. We identify previously unknown spatial and temporal differences in CMA activity in multiple organs and in response to stress. We illustrate the versatility of this model for monitoring CMA in live animals, organotypic cultures and cell cultures from these mice, and provide practical examples of multiorgan response to drugs that modulate CMA.

Product Number
Product Description

Methyl viologen dichloride hydrate, 98%
Acetaminophen, BioXtra, ≥99.0%
3-Methyladenine, autophagy inhibitor
Millicell Cell Culture Insert, 12 mm, hydrophilic PTFE, 0.4 µm, Hydrophilic PTFE cell culture insert with pore size of 0.4 µm used in a 24-well plate for Cell Attachment, Cell Culture, Cell Differentiation, Fluorescence & Low Protein Binding.
Monoclonal Anti-Actin antibody produced in mouse, clone AC-40, ascites fluid
Monoclonal Anti-MAP2 (2a+2b) antibody produced in mouse, clone AP-20, ascites fluid
Leupeptin, BioUltra, microbial, ≥95% (HPLC)